The Conversation (0)
Invictus MD Announces Binding LOI to Acquire 100 Percent Interest of Late Stage Applicant Under Health Canada's ACMPR
Feb. 07, 2017 09:17AM PST
Cannabis Investing NewsInvictus MD Strategies (CSE:IMH) has announced that it has entered into a binding letter of intent for an option to acquire 100 percent interest of the outstanding shares of late stage applicant under the Access to Cannabis for Medical Purposes Regulations from its current shareholders. As quoted in the press release: In early January 2017, …
Invictus MD Strategies (CSE:IMH) has announced that it has entered into a binding letter of intent for an option to acquire 100 percent interest of the outstanding shares of late stage applicant under the Access to Cannabis for Medical Purposes Regulations from its current shareholders.
As quoted in the press release:
In early January 2017, OptionCo had its Pre-license inspection from Health Canada and expects to receive a license to cultivate under the ACMPR in short order.
OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres (the “Property”), which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility. Assuming OptionCo receives the requisite regulatory approval to cultivate, OptionCo has future expansion plans on the 150 acre Property to establish itself as a leader in the Canadian cannabis industry.
The Option will be exercisable at the sole option of Invictus MD within 30 days after OptionCo receives its license to cultivate under the ACMPR. The exercise price of the Option will be payable as follows: (i) cash payment of $4 million CDN to the Vendors; (ii) issuing to the Vendors within 10 business days of exercising the Option, 21 million common shares of Invictus MD; and (iii) issuing to the Vendors 3 million warrants with an exercise price of $1.50 per warrant, of which: 1 million warrants will expire in 6 months following the date the Option is exercised; 1 million warrants will expire in 12 months following the date the Option is exercised, and 1 million warrants will expire in 18 months following the date the Option is exercised.
Subject to completion of satisfactory due diligence, Invictus MD intends to enter into a definitive option agreement on or before February 24, 2017.
